Drug Type Small molecule drug  | 
Synonyms-  | 
Target  | 
Action agonists  | 
Mechanism TRPML1 agonists(mucolipin 1 agonists)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhaseDiscovery  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neurodegenerative Diseases | Discovery | United States   | 01 Aug 2024 | 





